Masahiro Yagi

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI

Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto et al. · JAMA · 2019 · 834 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki et al. · JAMA Cardiology · 2022 · 300 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Clinical Characteristics of Hospitalized Heart Failure Patients with Preserved, Mid-Range, and Reduced Ejection Fractions in Japan

Tsuyoshi Shiga, Atsushi Suzuki, Shoji Haruta et al. · ESC Heart Failure · 2019 · 123 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial

Hirotoshi Watanabe, Takenori Domei, Takeshi Morimoto et al. · Cardiovascular Intervention and Therapeutics · 2020 · 62 citations

Medicine, Cardiology, Pharmacotherapy +16

Clopidogrel vs Aspirin Monotherapy Beyond 1 Year After Percutaneous Coronary Intervention

Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki et al. · Journal of the American College of Cardiology · 2023 · 62 citations

Medicine, Cardiology, Pharmacotherapy +12